Page 42 - ARNM-3-2
P. 42
Advances in Radiotherapy
& Nuclear Medicine Radiomics for gastric cancer
Methodology: Ziyang Liu, Wenhao Guo, Sunjun Li, Junhao Current topics and future perspective. World J Gastroenterol.
Ma, Yuxin Lou, Lijing Liu 2018;24(26):2818-2832.
Formal analysis: Congying Xie doi: 10.3748/wjg.v24.i26.2818
Writing – original draft: Qiao Zheng, Haoze Zheng
Writing – review & editing: Xiance Jin 9. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R.
Gastric cancer: Epidemiology, risk factors, classification,
Ethics approval and consent to participate genomic characteristics and treatment strategies. Int J Mol
Sci. 2020;21(11):4012.
Not applicable. doi: 10.3390/ijms21114012
Consent for publication 10. Seevaratnam R, Cardoso R, McGregor C, et al. How useful
is preoperative imaging for tumor, node, metastasis (TNM)
Not applicable. staging of gastric cancer? A meta-analysis. Gastric Cancer.
2012;15(Suppl 1):S3-S18.
Availability of data
doi: 10.1007/s10120-011-0069-6
Not applicable.
11. Johnston FM, Beckman M. Updates on management of
References gastric cancer. Curr Oncol Rep. 2019;21(8):67.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, doi: 10.1007/s11912-019-0820-4
Jemal A. Global cancer statistics 2018: GLOBOCAN estimates 12. Bi WL, Hosny A, Schabath MB, et al. Artificial intelligence
of incidence and mortality worldwide for 36 cancers in 185 in cancer imaging: Clinical challenges and applications. CA
countries. CA Cancer J Clin. 2018;68(6):394-424. Cancer J Clin. 2019;69(2):127-157.
doi: 10.3322/caac.21492 doi: 10.3322/caac.21552
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 13. Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images are more
2020: GLOBOCAN estimates of incidence and mortality than pictures, they are data. Radiology. 2016;278(2):563-577.
worldwide for 36 cancers in 185 countries. CA Cancer J Clin. doi: 10.1148/radiol.2015151169
2021;71(3):209-249.
14. Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour
doi: 10.3322/caac.21660
phenotype by noninvasive imaging using a quantitative
3. Noh SH, Park SR, Yang HK, et al. Adjuvant capecitabine radiomics approach. Nat Commun. 2014;5:4006.
plus oxaliplatin for gastric cancer after D2 gastrectomy
(CLASSIC): 5-year follow-up of an open-label, randomised doi: 10.1038/ncomms5006
phase 3 trial. Lancet Oncol. 2014;15(12):1389-1396. 15. Wang Y, Jin ZY. Radiomics approaches in gastric cancer:
A frontier in clinical decision making. Chin Med J (Engl).
doi: 10.1016/S1470-2045(14)70473-5
2019;132(16):1983-1989.
4. Spolverato G, Ejaz A, Kim Y, et al. Rates and patterns of
recurrence after curative intent resection for gastric cancer: doi: 10.1097/CM9.0000000000000360
A United States multi-institutional analysis. J Am Coll Surg. 16. Zhang W, Fang M, Dong D, et al. Development and validation
2014;219(4):664-675. of a CT-based radiomic nomogram for preoperative
prediction of early recurrence in advanced gastric cancer.
doi: 10.1016/j.jamcollsurg.2014.03.062
Radiother Oncol. 2020;145:13-20.
5. Deng J, Liang H, Wang D, Sun D, Pan Y, Liu Y. Investigation doi: 10.1016/j.radonc.2019.11.023
of the recurrence patterns of gastric cancer following a
curative resection. Surg Today. 2011;41(2):210-215. 17. Jiang Y, Chen C, Xie J, et al. Radiomics signature of computed
tomography imaging for prediction of survival and
doi: 10.1007/s00595-009-4251-y
chemotherapeutic benefits in gastric cancer. EBioMedicine.
6. Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: Current status 2018;36:171-182.
of diagnosis and treatment. Cancers (Basel). 2013;5(1):48-63.
doi: 10.1016/j.ebiom.2018.09.007
doi: 10.3390/cancers5010048
18. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC,
7. Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-648.
Gastric cancer: Prevention, screening and early diagnosis. doi: 10.1016/S0140-6736(20)31288-5
World J Gastroenterol. 2014;20(38):13842-13862.
19. Zhang Q, Peng C. Cancer-associated fibroblasts regulate the
doi: 10.3748/wjg.v20.i38.13842
biological behaviour of cancer cells and stroma in gastric
8. Matsuoka T, Yashiro M. Biomarkers of gastric cancer: cancer. Oncol Lett. 2018;15(1):691-698.
Volume 3 Issue 2 (2025) 34 doi: 10.36922/arnm.8350

